The drug Ozempic not only propelled Novo Nordisk to the top of the largest European companies (in terms of capitalization), but also changed purchasing patterns in the US, Pekao economists note.
Source link
Poland was supposed to be "the second Japan". Now Denmark is to be our model. "An interesting point of reference"
